Target
GARP:TGF-β1 complex
1 abstract
Abstract
Livmoniplimab with or without budigalimab in patients with advanced solid tumors: Results from the combination therapy in the urothelial carcinoma dose expansion cohort.Org: Hospital Clínico Universitario-INCLIVIA, Valencia, Spain, Universite Catholique De Louvain, Bruxelles, Belgium, Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, VA New York Harbor Healthcare System, Manhattan Campus, New York, NY, Yonsei University Health System and Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea,